Poland· PL-100313990
Puregon
A follitropin beta product containing follitropinum beta, registered in Poland by N.V. Organon. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Follitropin beta is registered in 11 of 19 countries.
Countries holding a registration under ATC G03GA06 (follitropin beta), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Follitropin beta · ATC G03GA06
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Follitropinum beta
- Manufacturer
- N.V. Organon
- Country
- Poland (PL)
- ATC code
- G03GA06
- ATC class
- Follitropin beta
- Defined daily dose
- 75 E, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05901549325119
- gtin00191778013313
- gtin00840164508109
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Follitropin beta in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumFertavid 100 IU/0.5 mlMerck Sharp & Dohme
- FinlandFertavidMerck Sharp & Dohme B.V.
- IrelandPuregonN.V. Organon
- SwedenPuregon 100 IE/0,5 ml Injektionsvätska, lösningMerck Sharp & Dohme BV
- United KingdomPuregon 100units/0.5ml solution for injection vialsWaymade Healthcare Plc
- SpainFERTAVID 100 UI/0,5 ml SOLUCION INYECTABLEMerck Sharp & Dohme B.V.
- CzechiaPUREGONN.V. Organon, Oss
- IcelandPuregonN.V. Organon*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Puregon
- Liechtenstein · Puregon
- Norway · Puregon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f47d9877-1664-4d9f-b026-f76a978b7c7d GET /v1/drugs/f47d9877-1664-4d9f-b026-f76a978b7c7d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "900 j.m./1,08 ml (833 j.m./ml)",
"packaging": "05901549325119 ¦ Rpz ¦ Skasowane ¦ EU/1/96/008/041 ¦ 90657\n1 wkład 1,08 ml + 9 igieł\n00191778013313 ¦ Rpz ¦ Skasowane ¦ EU/1/96/008/041 ¦ 127234\n1 wkład 1,08 ml + 9 igieł\n00840164508109 ¦ Rpz ¦ EU/1/96/008/041 ¦ 143809\n1 wkład 1,08 ml + 9 igieł",
"substance": "Follitropinum beta 900 j.m./1,08 ml",
"common_name": "Follitropinum beta",
"pl_product_id": "100313990",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about follitropin beta.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.